Erlotinib, Crizotinib, Nivolumab: Big Three in ALCHEMIST Platform

Commentary Regarding Immune Checkpoint Inhibitors

Q&A with Jamie E. Chaft, MD, Regarding the ALCHEMIST Platform

A Surprising Career Advances Cancer Research: Margaret Foti, MD, PhD (hc)

IASLC Leader Elected President of ESMO for 2020–2021: Solange Peters, MD, PhD

Suicide and Lung Cancer: Screening Is Only the First Step

Q&A with Alice Shaw, MD, PhD

Q&A with Benjamin Solomon, MBBS, PhD, FRACP

Dziadziuszko Follows in Footsteps of Thoracic Oncology Icon, Receives Award in Heine Hansen’s Name

Interview with Bruce Johnson, MD, 2017-2018 ASCO President

A Life in Thoracic Oncology – Reflections from Giants on Milestones in the Treatment Advances in Lung Cancer

Welcome to Year Two of the IASLC Lung Cancer News